In Vitro Human Cell Line Models to Predict Clinical Response to Anticancer Drugs

N Niu, L Wang - Pharmacogenomics, 2015 - Taylor & Francis
In vitro human cell line models have been widely used for cancer pharmacogenomic studies
to predict clinical response, to help generate pharmacogenomic hypothesis for further …

Significance, detection and markers of disseminated breast cancer cells

M Lacroix - Endocrine-related cancer, 2006 - erc.bioscientifica.com
The development of distant metastases is the major cause of death from breast cancer. In
order to predict and prevent tumour spreading, many attempts are being made to detect …

A community effort to assess and improve drug sensitivity prediction algorithms

JC Costello, LM Heiser, E Georgii, M Gönen… - Nature …, 2014 - nature.com
Predicting the best treatment strategy from genomic information is a core goal of precision
medicine. Here we focus on predicting drug response based on a cohort of genomic …

CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set

WC Reinhold, M Sunshine, H Liu, S Varma, KW Kohn… - Cancer research, 2012 - AACR
High-throughput and high-content databases are increasingly important resources in
molecular medicine, systems biology, and pharmacology. However, the information usually …

A multivariate approach to the integration of multi-omics datasets

C Meng, B Kuster, AC Culhane, AM Gholami - BMC bioinformatics, 2014 - Springer
Background To leverage the potential of multi-omics studies, exploratory data analysis
methods that provide systematic integration and comparison of multiple layers of omics …

Global proteome analysis of the NCI-60 cell line panel

AM Gholami, H Hahne, Z Wu, FJ Auer, C Meng… - Cell reports, 2013 - cell.com
The NCI-60 cell line collection is a very widely used panel for the study of cellular
mechanisms of cancer in general and in vitro drug action in particular. It is a model system …

Putative DNA/RNA helicase Schlafen-11 (SLFN11) sensitizes cancer cells to DNA-damaging agents

G Zoppoli, M Regairaz, E Leo… - Proceedings of the …, 2012 - National Acad Sciences
DNA-damaging agents (DDAs) constitute the backbone of treatment for most human tumors.
Here we used the National Cancer Institute Antitumor Cell Line Panel (the NCI-60) to identify …

Discovery of multi-dimensional modules by integrative analysis of cancer genomic data

S Zhang, CC Liu, W Li, H Shen, PW Laird… - Nucleic acids …, 2012 - academic.oup.com
Recent technology has made it possible to simultaneously perform multi-platform genomic
profiling (eg DNA methylation (DM) and gene expression (GE)) of biological samples …

Mutation analysis of 24 known cancer genes in the NCI-60 cell line set

ON Ikediobi, H Davies, G Bignell, S Edkins… - Molecular cancer …, 2006 - AACR
The panel of 60 human cancer cell lines (the NCI-60) assembled by the National Cancer
Institute for anticancer drug discovery is a widely used resource. The NCI-60 has been …

CellMiner: a relational database and query tool for the NCI-60 cancer cell lines

UT Shankavaram, S Varma, D Kane, M Sunshine… - BMC genomics, 2009 - Springer
Background Advances in the high-throughput omic technologies have made it possible to
profile cells in a large number of ways at the DNA, RNA, protein, chromosomal, functional …